Keep trying shorty! LOL The management here has brought investors an absolutely great opportunity. Not only is the potential seeming to get larger by the month, the balance sheet unlike the vast majority of these biotech situations is excellent. All one needs to do, is check out the FACTS. Multiple partners, deals, drugs in trials, newly approved CABO with huge expansion promise, cashed up. It does not get much better. Oh forgot: a killer stock price at this time, brought to you by shorts and sundry other players. Who could ask for more! Not me!
Don't you just love it when I go on a posting binge! LOL